Main market
Access this stock data via API
Subscribe
Eli Lilly and Company
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 15.0B 13.3B 10.8B 11.5B
Cost of revenue 2.6B 2.1B 1.9B 2.0B
Gross profit 12.4B 11.2B 9.0B 9.5B
Operating expense
Research & development 3.0B 2.8B 2.3B 2.6B
Selling general and admin 2.2B 2.3B 2.0B 2.0B
Other operating expenses
Operating income 7.2B 6.1B 4.6B 4.9B
Non operating interest income
Income 55.4M 34.1M 41.2M 37.8M
Expense 153.1M 212.2M 207.7M 191.5M
Other income expense -982.7M -120.0M -1.5B -493.2M
Pretax income 6.2B 5.8B 2.9B 4.3B
Tax provision 1.4B 951.0M 593.8M 536.0M
Net income 4.8B 4.8B 2.4B 3.8B
Basic EPS 6.3 3.1 4.9
Diluted EPS 6.3 3.1 4.9
Basic average shares 765.2M 765.1M 764.9M
Diluted average shares 766.9M 767.5M 769.7M
EBITDA 7.5B 6.4B 5.0B 5.4B
Net income from continuing op. 4.8B 4.8B 2.4B 3.8B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 4 hours 52 minutes

12:42
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).